Comparison of the Effectiveness of Sambiloto Herbs (Andrographis Paniculata) and Brisk Walking Exercise on Blood Glucose of Obese Patients

July 21, 2024 updated by: Agnes Veronica Agustin, Universitas Palangka Raya

Problem Formulation

  1. Does herbal medicine sambiloto affect the blood glucose levels of obese sufferers?
  2. Does brisk walking affect blood glucose levels in obese sufferers?
  3. Does the combination of bitter herbal medicine and brisk walking have an effect on blood glucose levels in obese sufferers?
  4. Is there a difference in the effectiveness between herbal bitter and brisk walking and the combination on blood glucose levels in obese sufferers?

Research Objectives

General Objectives :

The general aim of this research is to determine the difference in effectiveness between the herbal medicine Sambiloto and brisk walking as well as the combination on the blood glucose levels of obese sufferers.

Specific Objective :

  1. Knowing the effect of herbal medicine Sambiloto on blood glucose in obese sufferers.
  2. Knowing the effect of brisk walking on blood glucose in obese sufferers.
  3. To determine the effect of the combination of herbal medicine Sambiloto and brisk walking on blood glucose levels in obese sufferers.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Detailed Description

This type of research uses the Quasi Experimental method type Non-equivalent control group design, with a research design in the form of two group pre test and post test design, in this study there are two groups that will be measured pretest before intervention and post test after intervention and 1 control group without being given intervention. The intervention group is divided into two groups, namely the group given the herbal medicine sambiloto, and the group given the Brisk Walking Exercise treatment. Quasi-experimental research design with research design in the form of two group pre test and post test design.

Study Type

Interventional

Enrollment (Estimated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Willing to be a respondent with informed consent
  2. Obesity sufferers in the Jekan Raya District area
  3. Have a BMI ≥ 25 kg/m2 (Obesity I)
  4. Adult age (19-39 years)

Exclusion Criteria:

  1. Not being present or out of town during the research
  2. Unable to continue research due to serious illness or death
  3. Withdraw while participating in the research
  4. Have a history of drug allergies
  5. Experiencing decreased consciousness
  6. Experiencing an extremity injury
  7. Have a history of cardiovascular disease, kidney disease or stomach ulcers
  8. Have a history of bloody stools
  9. Are pregnant or breastfeeding

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Brisk Walking
Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.
Behavioral: Brisk Walking
Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.
Experimental: Herbal Medicine Sambiloto
Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Dietary supplement: Herbal Medicine Sambiloto
Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Experimental: Combination

Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute.

Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days.
Combination product: Brisk Walking and Herbal Medicine Sambiloto
Moderate activity that uses brisk walking techniques for 30 minutes at an average speed of up to 5 km/h or 100 steps per minute. Jamu Sambiloto is herbal medicine obtained through products that already have a distribution permit and have a distribution permit registration number, with a consumption dose of 1 capul / day or 350 grams for 7 consecutive days
No Intervention: Control Obese
Obese with no intervention
No Intervention: Control Normal
Normal with no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood Glucose Differences
Time Frame: 7 consecutive day
Difference in blood glucose before and after treatment
7 consecutive day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Universitas Palangka Raya

Investigators

  • Principal Investigator: Agnes Veronica Agustin, Universitas Palangka Raya

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 21, 2024

Primary Completion (Estimated)

August 1, 2024

Study Completion (Estimated)

September 1, 2024

Study Registration Dates

First Submitted

July 21, 2024

First Submitted That Met QC Criteria

July 21, 2024

First Posted (Actual)

July 25, 2024

Study Record Updates

Last Update Posted (Actual)

July 25, 2024

Last Update Submitted That Met QC Criteria

July 21, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2504031946

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on MeSH

Clinical Trials on Brisk Walking

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kyrgyzstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe